CELLULE STELLATE EPATICHE E DANNO METABOLICO. Fabio Marra Dipartimento di Medicina Interna Centro di Eccellenza DenoTHE Università di Firenze

Size: px
Start display at page:

Download "CELLULE STELLATE EPATICHE E DANNO METABOLICO. Fabio Marra Dipartimento di Medicina Interna Centro di Eccellenza DenoTHE Università di Firenze"

Transcription

1 CORSO UNIGASTRO San Vincenzo 4-6 Maggio 2008 CELLULE STELLATE EPATICHE E DANNO METABOLICO Fabio Marra Dipartimento di Medicina Interna Centro di Eccellenza DenoTHE Università di Firenze ITALY

2 Bataller & Brenner J Clin Invest 2005;115:209

3 All Roads lead to Rome! Fibrosis ASH AIH NASH HCV HBV Biliary Iron Vascular

4 Characteristics of NASH Steatosis plus: Necro-inflammatory foci with mononuclear cells +/- neutrophils Ballooning degeneration of hepatocytes +/- Mallory bodies Pericellular fibrosis

5 Marra et al, Trends Mol Med 2008;14:72-81

6 Courtesy of SL Friedman

7 The in vitro models Cultured HSC Activated by culture on plastic hrs after plating. Artificial bidimensional support. May be compared with cells isolated from animals with hepatic fibrosis.

8 Gene expression in HSC isolated in vitro or in vivo De Minicis et al., Gastroenterology 2007;132:1937

9 Hepatic stellate cells: the effectors of liver wound healing Modified from Friedman, J Biol Chem 2000;275:

10 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

11 Fibrosis and inflammation: a complex relationship Inflammation during active fibrogenesis Expression of ROS and fibrogenic cytokines NK cells Antifibrogenic, kill activated HSC Macrophages after cessation of injury Expression of MMPs and fibrosis reversal

12 Friedman, Physiol Rev 2008;88:125

13 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

14 HSC as targets of oxidative stress-related products Direct effect Cross-talk with cytokine signaling Formation of adducts ROS Cytotoxic effects HNE Acetaldehyde Collagen TIMPs MCP-1 MMP-2 Migration Proliferation Collagen TIMP-1 MCP-1 Parola et al. BBRC 1996;222:261 Svegliati Baroni et al., Hepatology 1998 Parola et al., J Clin Invest 1999;102:1942 Nieto et al., J Biol Chem 2002; 277:9853

15 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

16 Insulin and IGF-I I as mitogens for HSC Svegliati Baroni et al., Hepatology 1999;29:1743

17 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

18 HSC express receptors for advanced glycation end-products Fehrenbach et al., Hepatology 2001;34:943

19 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

20 Cannabinoid receptor activation differentially affect liver fibrosis Rimonabant CB1 FIBROSIS Teixeira-Clerc et al. Nat Med 2006;12:671

21 CB1 antagonism improves steatosis Gary-Bobo et al., Hepatology 2007;46:122

22 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

23 Nuclear hormone receptors and hepatic fibrosis Inhibitor Stimulant PPAR-α PPAR-γγ PPAR-β (-δ) RAR PXR FXR LXR? Inhibits the activated phenotype of HSC Collagen Proliferation Inflammatory molecules Inhibits fibrosis in vivo but is less effective if added after the onset of damage Marra et al., Gastroenterology 2000;119:466 Miyahara et al., J Biol Chem 2000;275:35715 Galli et al., Gastroenterology 2002;122:1924 Leclercq et al., Gut 2006;55:1020

24 The fat paradox Tsukamoto, Keio J Med 2005;54:190

25 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

26 LPS LTA PGN Toll-like Pattern recognition receptors Activation of KC and inflammatory cells MCP-1 TGF-β Hepatic stellate cells TLR4 TLR2 PGRP-L CD14 PGRP-S Paik et al., Hepatology 2003;37:1043 Brun et al., AJP-GI : G571 Seki et al. Nat Med 2007;13:1324

27 TLR4 inhibits TGF-β signaling via Bambi Seki et al. Nat Med 2007;13:1324

28 Modulators of stellate cell biology with relevance to NASH Inflammation Oxidative stress Insulin Activation of receptors for advanced glycation end-products Cannabinoids Nuclear hormone receptors Pattern recognition receptors Adipokines

29 Després & Lemieux, Nature 2006; 444:847

30 Adipokines: implications for fibrosis Cortisone 11β-HSD1 Cortisol FFA Androstenedione Estrone Leptin Complement factors Adipsin/D Visfatin Angiotensinogen PAI-1 TNF-α MCP-1 IL-6 Resistin Adiponectin

31 Leptin H 2 O 2 Jak-Stat ERK p38 MAPK AP-1 H 2 O 2 Jak-Stat ERK p38 MAPK ERK PI3K/Akt ERK PI3K/Akt NF-κB HIF-1α Type I Collagen TIMP-1 Proliferation Survival Chemokines VEGF Marra, J Hepatol 2007;46:

32 Leptin induces the expression of VEGF by HSC via HIF-1 Control Leptin Hypoxia Aleffi et al., Hepatology 2005;42:1339

33 Leptin activates the mtor pathway

34 Leptin induces angiogenesis g and neoplastic foci in vivo Kitade et al., Hepatology 2006;44:983

35 Adipokines: implications for fibrosis Cortisone 11β-HSD1 Cortisol FFA Androstenedione Estrone Leptin Complement factors Adipsin/D Visfatin Angiotensinogen PAI-1 TNF-α MCP-1 IL-6 Resistin Adiponectin

36 Adipokines modulate NF-kB and MCP-1 in liver myofibroblasts 2,8 * fold increase) 2,1 1,4 kb kb kb Luc IL-8 (-f MCP-1 (-f fold increase) 0, Cnt Resistin IL-8 * * Cnt Rst 24 Rst 48 Lu uciferase e activity 25 2,5 2 1,5 1 0,5 0 * Control Resistin MCP-1 Bertolani et al., Am J Pathol 2006; 169:2042

37 Adipokines: implications for fibrosis Cortisone 11β-HSD1 Cortisol FFA Androstenedione Estrone Leptin Complement factors Adipsin/D Visfatin Angiotensinogen PAI-1 TNF-α MCP-1 IL-6 Resistin Adiponectin

38 Adiponectin and NASH It is negatively correlated with obesity and the metabolic syndrome Ameliorates glucose and lipid metabolism in murine models Reduces fibrosis in a toxic model Inhibits activation of HSC

39 Adiponectin and its receptors Kadowaki et al., J Clin Invest 2006; 116:1784

40 AICAR Biguanides Thiazolidinediones Modified from Long & Zierath, J Clin Invest 2006; 116:1776

41 AMPK activation inhibits the pro- fibrogenic phenotype of HSC Caligiuri, Bertolani et al., Hepatology 2008;47:668

42 AICAR inhibits other features of the activated HSC phenotype Caligiuri, Bertolani et al., Hepatology 2008;47:668

43 Metformin has antifibrogenic effects Caligiuri, Bertolani et al., Hepatology 2008;47:668

44 Marra et al, Trends Mol Med 2008;14:72-81

Steatosi, infiammazione e fibrosi: meccanismi patogenetici e interazioni

Steatosi, infiammazione e fibrosi: meccanismi patogenetici e interazioni Steatosi, infiammazione e fibrosi: meccanismi patogenetici e interazioni Fabio Marra Dipartimento di Medicina Sperimentale e Clinica University of Florence, Italy f.marra@dmi.unifi.it Female, 72 years

More information

THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points

THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points December 2008 (Vol. 1, Issue 3, pages 36-40) THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES By Sophie Lotersztajn, PhD, Ariane Mallat, MD, PhD Inserm U841, Hôpital Henri Mondor,

More information

Fattori implicati nel rimodellamento tissutale epatico

Fattori implicati nel rimodellamento tissutale epatico tissutale epatico Dr. Simone Carotti Unità di Ricerca di Anatomia Microscopica e Ultrastrutturale Facoltà Dipartimentale di Medicina e Chirurgia Background Duncan AW, Dorrell C, Grompe M. Gastroenterology.

More information

Give a NOD to diabetes:

Give a NOD to diabetes: Give a NOD to diabetes: NOD proteins ti link immunity it and metabolism tbli Jonathan Schertzer McMaster University McMaster University Faculty of Health Sciences Department of Biochemistry and Biomedical

More information

NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center

NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center NASH: It is not JUST a Fatty Liver Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center Stages of Fatty Liver Disorders Fatty Liver 16-35% of Western

More information

Antioxidant response in patients with chronic hepatitis B or C.

Antioxidant response in patients with chronic hepatitis B or C. Antioxidant response in patients with chronic hepatitis B or C. Kamila Wójcik, Anna Piekarska, Elżbieta Jabłonowska Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland

More information

Overvekt, mer enn bare overvekt

Overvekt, mer enn bare overvekt Overvekt, mer enn bare overvekt Kurs Overvekt i svangerskap og fødsel Overvekt/fedme i historisk perspektiv I løpet av1-2 generasjoner har det vært en økning i forekomsten av fedme som er historisk uovertroffen.

More information

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia Pathogenesis of Dengue Natalia Taborda Vanegas Doc. Sci. Student Immunovirology Group Universidad de Antioquia Infection process Epidermis keratinocytes Dermis Archives of Medical Research 36 (2005) 425

More information

HIGHLIGHTS FROM THE AASLD MEETING. Rob Goldin. Imperial College Faculty of Medicine at St Mary s r.goldin@imperial.ac.uk

HIGHLIGHTS FROM THE AASLD MEETING. Rob Goldin. Imperial College Faculty of Medicine at St Mary s r.goldin@imperial.ac.uk HIGHLIGHTS FROM THE AASLD MEETING Rob Goldin Imperial College Faculty of Medicine at St Mary s r.goldin@imperial.ac.uk What was on at the meeting? 1. Postgraduate Course 2. Oral Presentations 3. Poster

More information

Non Alcoholic Fatty Liver. Dott.ssa Elisabetta Bugianesi Divisione di Gastro-epatologia Università di Torino

Non Alcoholic Fatty Liver. Dott.ssa Elisabetta Bugianesi Divisione di Gastro-epatologia Università di Torino Savona, 10 aprile 2010 Non Alcoholic Fatty Liver Non Alcoholic Steatohepatitis Dott.ssa Elisabetta Bugianesi g Divisione di Gastro-epatologia Università di Torino The Spectrum of NAFLD Fatty Liver NASH

More information

Subject Index. Bariatric surgery, obesity management 134

Subject Index. Bariatric surgery, obesity management 134 Subject Index Acromegaly, PCOS differential diagnosis 149, 150, 154, 155 Adipokines, see specific adipokines Adiponectin, metabolic syndrome role 41 43 Adolescents, PCOS diagnosis 16, 17 Adrenal hyperplasia,

More information

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized

More information

TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS.

TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS. TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS. The nomenclature of cytokines partly reflects their first-described function and also the order of their discovery. There is no single unified nomenclature,

More information

Diabetes and Obesity. The diabesity epidemic

Diabetes and Obesity. The diabesity epidemic Diabetes and Obesity Frank B. Diamond, Jr. M.D. Professor of Pediatrics University of South Florida College of Medicine The diabesity epidemic Prevalence of diabetes worldwide was over 135 million people

More information

Boehringer Ingelheim- sponsored Satellite Symposium. HCV Beyond the Liver

Boehringer Ingelheim- sponsored Satellite Symposium. HCV Beyond the Liver Boehringer Ingelheim- sponsored Satellite Symposium HCV Beyond the Liver HCV AS A METABOLIC MODIFIER: STEATOSIS AND INSULIN RESISTANCE Francesco Negro University Hospital of Geneva Switzerland Clinical

More information

Fat and Viral Liver Disease

Fat and Viral Liver Disease Fat and Viral Liver Disease Francesco Negro Viropathology Unit University of Geneva Medical Center Geneva, Switzerland Mainz, September 20, 2008 Steatosis and HBV Steatosis in HBV infection: prevalence

More information

Fat: A matter of disturbance for the immune system

Fat: A matter of disturbance for the immune system Online Submissions: http://www.wjgnet.com/1007-9327office wjg@wjgnet.com doi:10.3748/wjg.v16.i38.4762 World J Gastroenterol 2010 October 14; 16(38): 4762-4772 ISSN 1007-9327 (print) ISSN 2219-2840 (online)

More information

Intracellular fat deposition

Intracellular fat deposition Who Gets Alcoholic Liver Disease? Chris Day Newcastle University Alcoholic Fatty Liver (Steatosis) Fatty hepatocytes Intracellular fat deposition Alcoholic SteatoHepatitis (ASH) Fat deposits Inflammation

More information

Gene Silencing Oligos (GSOs) Third Generation Antisense

Gene Silencing Oligos (GSOs) Third Generation Antisense Gene Silencing Oligos (GSOs) Third Generation Antisense Walter R. Strapps, Ph.D. Executive Director, RNA Therapeutics Idera Pharmaceuticals Cambridge, MA NASDAQ: IDRA www.iderapharma.com Idera is a leader

More information

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH) Int. J. Mol. Sci. 2014, 15, 7352-7379; doi:10.3390/ijms15057352 Review OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Molecular Mechanisms and New Treatment

More information

BIOM 255 - Firestein, Winter 2009. Rheumatoid arthritis. Page 1

BIOM 255 - Firestein, Winter 2009. Rheumatoid arthritis. Page 1 Rheumatoid arthritis Page 1 Vascular events in RA Synovium in rheumatoid arthritis Non-extra articular RA Extra articular RA Turesson, et al. Ann Rheum Dis. 2007;66:60 Normal Rheumatoid Arthritis Major

More information

Functional properties of fructans and their potential role in management of intestinal inflammatory pathologies

Functional properties of fructans and their potential role in management of intestinal inflammatory pathologies Functional properties of fructans and their potential role in management of intestinal inflammatory pathologies Dr.ssa Valentina Pasqualetti Unità di Ricerca di Scienze degli Alimenti e della Nutrizione

More information

Effets biologiques des facteurs de croissance sur la régénération musculaire

Effets biologiques des facteurs de croissance sur la régénération musculaire Effets biologiques des facteurs de croissance sur la régénération musculaire Xavier Bigard (MD, PhD) Professeur Agrégé du Val-de-Grâce Institut de Recherche Biomédicale des Armées (IRBA) La Tronche (Grenoble)

More information

Understanding the immune response to bacterial infections

Understanding the immune response to bacterial infections Understanding the immune response to bacterial infections A Ph.D. (SCIENCE) DISSERTATION SUBMITTED TO JADAVPUR UNIVERSITY SUSHIL KUMAR PATHAK DEPARTMENT OF CHEMISTRY BOSE INSTITUTE 2008 CONTENTS Page SUMMARY

More information

M. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2

M. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2 M. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2 1 Department of Physics, University of Pavia, Pavia, Italy 2 Istituto Nazionale

More information

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:

More information

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18

More information

Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome

Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual

More information

EFFECTS OF IRON ON THE IMMUNE SYSTEM

EFFECTS OF IRON ON THE IMMUNE SYSTEM EFFECTS OF IRON ON THE IMMUNE SYSTEM Gert Mayer Department of Internal Medicine IV (Nephrology and Hypertension) Medical University Innsbruck Austria Conflicts of interest Research Support: Amgen, Roche,

More information

Summary and conclusion 2013

Summary and conclusion 2013 The work presented in the thesis is focused on the problems related to the prostate gland. Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are the two major problems associated with prostate.

More information

Designing Visfatin inhibitors to limit its Insulin Mimcy and Type II Diabetes.

Designing Visfatin inhibitors to limit its Insulin Mimcy and Type II Diabetes. Designing Visfatin inhibitors to limit its Insulin Mimcy and Type II Diabetes. Neha Pandya, 1 Earl Benjamin, 1 Ellis Benjamin* 1 Department of Chemistry, The Richard Stockton College of New Jersey, Galloway

More information

Immunological studies, fibrosis and oxidative stress

Immunological studies, fibrosis and oxidative stress Pathogenesis of hepatitis C virus (HCV) infection: role of genetic, immunologic and environmental factors in HCV-related liver disease and in symptomfree HCV carriers. Hepatitis C virus (HCV) infection

More information

Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research?

Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,

More information

Overvekt, mer enn bare overvekt

Overvekt, mer enn bare overvekt Overvekt, mer enn bare overvekt Kurs Overvekt i svangerskap og fødsel Overvekt/fedme i historisk perspektiv I løpet av1-2 generasjoner har det vært en økning i forekomsten av fedme som er historisk uovertroffen.

More information

Drug Development Services

Drug Development Services Drug Development Services USING BLOOD AND BONE MARROW PRIMARY CELL SYSTEMS Clinically Relevant In Vitro Assays Broad Spectrum of Drug Classes Multi-Species Platforms Enhancing Drug Development through

More information

How To Understand The Effects Of A Drug On Your Health

How To Understand The Effects Of A Drug On Your Health Farmacologia degli inibitori TK e mtor Romano Danesi Professore ordinario di Farmacologia UOC Farmacologia Universitaria Azienda Ospedaliero-Universitaria Pisana Dipartimento di Medicina Interna Università

More information

HEPATIC FIBROSIS AND CIRRHOSIS

HEPATIC FIBROSIS AND CIRRHOSIS Ch006-X2998.qxd 3/15/06 5:21 PM Page 87 Section I: Pathophysiology of the Liver HEPATIC FIBROSIS AND CIRRHOSIS 6 Don C. Rockey and Scott L. Friedman Abbreviations ALT alanine aminotransferase AST aspartate

More information

STEM CELL FELLOWSHIP

STEM CELL FELLOWSHIP Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell

More information

Non-alcoholic fatty liver disease: Prognosis and Treatment

Non-alcoholic fatty liver disease: Prognosis and Treatment Non-alcoholic fatty liver disease: Prognosis and Treatment Zachary Henry, M.D. Assistant Professor UVA Gastroenterology & Hepatology October 28, 2015 Overview Case Presentation Prognosis Effects of fibrosis

More information

Corporate Presentation

Corporate Presentation Corporate Presentation November 2013 NASDAQ: GALT www.galectintherapeutics.com Forward Looking Statements This presentation contains, in addition to historical information, statements that look forward

More information

Autoimmunity and immunemediated. FOCiS. Lecture outline

Autoimmunity and immunemediated. FOCiS. Lecture outline 1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic

More information

Cryoinjury of Breast Cancer Cells in Tissue Equivalent Constructs

Cryoinjury of Breast Cancer Cells in Tissue Equivalent Constructs Cryoinjury of Breast Cancer Cells in Tissue Equivalent Constructs Bumsoo Han Department of Mechanical and Aerospace Engineering University of Texas at Arlington Cryosurgery Minimally invasive surgical

More information

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Andrew T. Gewirtz et al N A T U R E VOL 519 5 M A R C H 2 0 1 5 Background Incidence of IBD Fact 1: increasing

More information

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic Pulling the Plug on Cancer Cell Communication Stephen M. Ansell, MD, PhD Mayo Clinic Why do Waldenstrom s cells need to communicate? Waldenstrom s cells need activating signals to stay alive. WM cells

More information

Beneficial effects of CCR1 blockade on the progression of chronic allograft nephropathy

Beneficial effects of CCR1 blockade on the progression of chronic allograft nephropathy Beneficial effects of CCR1 blockade on the progression of chronic allograft nephropathy J. Bedke 1,2, E. Kiss 2, L. Schaefer 3, M. Bonrouhi 2, N. Gretz 4, H.-J. Gröne 2 1 Klinik für Urologie, Universität

More information

Genetics BRCA1 and BRCA2 are gene mutations which give 5 percent genetic risk of breast and ovary cancers. Worse if they drink alcohol.

Genetics BRCA1 and BRCA2 are gene mutations which give 5 percent genetic risk of breast and ovary cancers. Worse if they drink alcohol. Cancer seminar Ginseng & Dang Gui 10 Chinese formula to help cancer patients with energy. Cell Protect Green tea and turmeric increases efficacy as it helps cancer drugs to stay in cell i.e. reduce drug

More information

Prof. Marcello Persico. SECONDA UNIVERSITÀ DEGLI STUDI DI NAPOLI Cattedra di Medicina Interna

Prof. Marcello Persico. SECONDA UNIVERSITÀ DEGLI STUDI DI NAPOLI Cattedra di Medicina Interna 9 11 Marzo 2011 III Sessione The New Era of Host-Related Genetic Markers in HCV disease and Treatment: SOCS SNP and response to antiviral treatment Prof. Marcello Persico SECONDA UNIVERSITÀ DEGLI STUDI

More information

ALPHA (TNFa) IN OBESITY

ALPHA (TNFa) IN OBESITY THE ROLE OF TUMOUR NECROSIS FACTOR ALPHA (TNFa) IN OBESITY Alison Mary Morris, B.Sc (Hons) A thesis submitted to Adelaide University for the degree of Doctor of Philosophy Department of Physiology Adelaide

More information

LA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti. Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova

LA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti. Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova LA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova HBV ed HCV Due virus Diversi ma con molte Cose in Comune

More information

DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES

DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES Page 1 DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES Drugs to know are: Actrapid HM Humulin R, L, U Penmix SUNALI MEHTA The three principal hormones produced by the pancreas are: Insulin: nutrient metabolism:

More information

Non-alcoholic Fatty Liver Disease (NAFLD): Does Anything Help?

Non-alcoholic Fatty Liver Disease (NAFLD): Does Anything Help? Non-alcoholic Fatty Liver Disease (NAFLD): Does Anything Stephen Caldwell, MD Director of Hepatology University of Virginia Case: 36 yo F, T2 DM, abn liver enzymes, mother died of cryptogenic cirrhosis

More information

Non Alcoholic Steato-Hepatitis (NASH)

Non Alcoholic Steato-Hepatitis (NASH) Non Alcoholic Steato-Hepatitis (NASH) DISCLAIMER NEITHER THE PUBLISHER NOR THE AUTHORS ASSUME ANY LIABILITY FOR ANY INJURY AND OR DAMAGE TO PERSONS OR PROPERTY ARISING FROM THIS WEBSITE AND ITS CONTENT.

More information

Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System

Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment Bruce Latham, M.D. Endocrine Specialists Greenville Health System Objectives for this presentation - Understand the thrifty genotype

More information

October 18 & 19, 2007 Kobe, Japan. Program: Oral and Poster Abstracts. The Portopia Hotel Southwing and Kobe International Exhibition Hall 1

October 18 & 19, 2007 Kobe, Japan. Program: Oral and Poster Abstracts. The Portopia Hotel Southwing and Kobe International Exhibition Hall 1 2nd International Symposium October 18 & 19, 2007 Kobe, Japan The Portopia Hotel Southwing and Kobe International Exhibition Hall 1 Program: Oral and Poster Abstracts Cell Death and Survival Mechanisms

More information

Pathophysiology of Type 2 Diabetes and Its Treatment Policy

Pathophysiology of Type 2 Diabetes and Its Treatment Policy Research and Reviews Pathophysiology of Type 2 Diabetes and Its Treatment Policy JMAJ 53(1): 41 46, 2010 Kohei KAKU* 1 Abstract Impaired insulin secretion and increased insulin resistance, the main pathophysiological

More information

New Approaches to Treating Fatty Liver Disease. Mack C. Mitchell, MD University of Texas Southwestern Medical Center Dallas, Texas

New Approaches to Treating Fatty Liver Disease. Mack C. Mitchell, MD University of Texas Southwestern Medical Center Dallas, Texas New Approaches to Treating Fatty Liver Disease Mack C. Mitchell, MD University of Texas Southwestern Medical Center Dallas, Texas Disclosures Stockholder: Bristol-Myers Squibb, Medtronic, Novartis, Pfizer

More information

GloP1r - A New Frontier in Exercise and Nutrition

GloP1r - A New Frontier in Exercise and Nutrition Central Florida Research Update Ayala, Julio, PhD, Sanford-Burnham Medical Research Institute, Orlando, Florida Anorectic Mechanisms of Glp1r Agonists Obesity Jan 1, 2014 Dec 31, 2018 Integrated Physiology,

More information

Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies. Biochemistry Journal. August 1, 2007 405, pp.

Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies. Biochemistry Journal. August 1, 2007 405, pp. Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies 1 Biochemistry Journal August 1, 2007 405, pp. 559 568 Joseph Friedman, Sarah Kraus, Yirmi Hauptman, Yoni Schiff

More information

Cancer treatment and diabetes

Cancer treatment and diabetes Cancer treatment and diabetes Dr Daniel Morganstein Consultant Endocrinologist, 1 2 Diabetes and cancer Cancer and its treatment also poses challenges to managing diabetes Surgery Altered appetite Cachexia

More information

Non Alcoholic Fatty Liver Disease

Non Alcoholic Fatty Liver Disease Linköping University Medical Dissertations No. 1081 Non Alcoholic Fatty Liver Disease A clinical and histopathological study Mattias Ekstedt Division of Gastroenterology and Hepatology Department of Clinical

More information

Les liasons dangerouses: infiammazione e cancro

Les liasons dangerouses: infiammazione e cancro Dipartimento di Diagnostica per Immagini e Medicina di Laboratorio Department of Morphology, Surgery and Experimental Medicine Center of Excellence MIUR for the Study of Inflammation (ICSI) Ferrara University

More information

Which drugs should be used to treat diabetes in cirrhotic patients?

Which drugs should be used to treat diabetes in cirrhotic patients? Which drugs should be used to treat diabetes in cirrhotic patients? Frankfurt am Main 10-12 September 2015 Jörg Bojunga Medizinische Klinik I Johann Wolfgang Goethe-Universität Frankfurt am Main Significance

More information

Nutrigenomics Bill of fare and genetic code. -Omics. -omics Technologies. Fingerprinting. Transcriptomics

Nutrigenomics Bill of fare and genetic code. -Omics. -omics Technologies. Fingerprinting. Transcriptomics Nutrigenomics Bill of fare and genetic code Regulation der Genexpression durch Nährstoffe Biozentrum Medizinische Biochemie florian.ueberall@i-med.ac.at -Omics -omics Technologies Transcriptomics Fingerprinting

More information

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1 AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL

More information

New Approaches to a Major Public-Health Problem Infectious Diseases. Ethan Weiner, M.D. Senior Vice President Therapeutic Area Development Head

New Approaches to a Major Public-Health Problem Infectious Diseases. Ethan Weiner, M.D. Senior Vice President Therapeutic Area Development Head New Approaches to a Major Public-Health Problem Infectious Diseases Ethan Weiner, M.D. Senior Vice President Therapeutic Area Development Head Overview The Burden Of Infectious Disease Is Large And May

More information

Introduction. Pathogenesis of type 2 diabetes

Introduction. Pathogenesis of type 2 diabetes Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic

More information

Chapter 8. Summary and Perspectives

Chapter 8. Summary and Perspectives Chapter 8 Summary and Perspectives 131 Chapter 8 Summary Overexpression of the multidrug resistance protein MRP1 confer multidrug resistance (MDR) to cancer cells. The contents of this thesis describe

More information

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,

More information

Diabetes and Drug Development

Diabetes and Drug Development Diabetes and Drug Development Metabolic Disfunction Leads to Multiple Diseases Hypertension ( blood pressure) Metabolic Syndrome (Syndrome X) LDL HDL Lipoproteins Triglycerides FFA Hyperinsulinemia Insulin

More information

Immunosuppressive drugs

Immunosuppressive drugs Immunosuppressive drugs RJM ten Berge Afd. Inw. Geneeskunde AMC contents overview targets mechanism of action Effects on immune capacity measured by responses to vaccination Immune response 1 calcineurin

More information

B Cells and Antibodies

B Cells and Antibodies B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production

More information

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Cancer Cells Cancer, the 1st leading cause of death, is an example of a disease that arises from abnormalities in cell function

More information

Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome

Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome Research and Reviews Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome JMAJ 53(4): 236 242, 2010 Hiromasa ISHII,* 1 Yoshinori HORIE,* 2 Yoshiyuki YAMAGISHI,* 3 Hirotoshi EBINUMA* 3 Abstract

More information

Product Datasheet. Secreted Alkaline Phosphatase Reporter Kit NBP2-25285. Unit Size: 1 Kit. Storage is content dependent.

Product Datasheet. Secreted Alkaline Phosphatase Reporter Kit NBP2-25285. Unit Size: 1 Kit. Storage is content dependent. Product Datasheet Secreted Alkaline Phosphatase Reporter Kit NBP2-25285 Unit Size: 1 Kit is content dependent. Publications: 6 Protocols, Publications, Related Products, Reviews, Research Tools and Images

More information

Rheumatoid arthritis: an overview. Christine Pham MD

Rheumatoid arthritis: an overview. Christine Pham MD Rheumatoid arthritis: an overview Christine Pham MD RA prevalence Chronic inflammatory disease affecting approximately 0.5 1% of the general population Prevalence is higher in North America (approaching

More information

In Vivo and In Vitro Screening for Thyroid Hormone Disruptors

In Vivo and In Vitro Screening for Thyroid Hormone Disruptors In Vivo and In Vitro Screening for Thyroid Hormone Disruptors Kevin M. Crofton National lhealth and Environmental Research Laboratory California Environmental Protection Agency Human Health Hazard Indicators

More information

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

Hapten - a small molecule that is antigenic but not (by itself) immunogenic. Chapter 3. Antigens Terminology: Antigen: Substances that can be recognized by the surface antibody (B cells) or by the TCR (T cells) when associated with MHC molecules Immunogenicity VS Antigenicity:

More information

Describe how these hormones exert control quickly by changes in phosphorylation state of enzyme, and more slowly by changes of gene expression

Describe how these hormones exert control quickly by changes in phosphorylation state of enzyme, and more slowly by changes of gene expression Section VIII. Section VIII. Tissue metabolism Many tissues carry out specialized functions: Ch. 43 look at different hormones affect metabolism of fuels, especially counter-insulin Ch. 44 Proteins and

More information

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational

More information

Chapter 45: Hormones and the Endocrine System

Chapter 45: Hormones and the Endocrine System Name Period Overview 1. What is a hormone? 2. Why does a hormone elicit a response only with target cells? 3. The body has two long-distance regulating systems. Which involves chemical signals by hormones?

More information

Technological platforms

Technological platforms Advitech Advitech is a life sciences & technology company Its mission is to discover and commercialize proprietary and evidence-based natural health products Focus on milk, whey and bovine colostrum R&D,

More information

岑 祥 股 份 有 限 公 司 技 術 專 員 費 軫 尹 20100803

岑 祥 股 份 有 限 公 司 技 術 專 員 費 軫 尹 20100803 技 術 專 員 費 軫 尹 20100803 Overview of presentation Basic Biology of RNA interference Application of sirna for gene function? How to study mirna? How to deliver sirna and mirna? New prospects on RNAi research

More information

Research in IBD at University of Colorado Denver

Research in IBD at University of Colorado Denver Research in IBD at University of Colorado Denver Blair Fennimore, MD Assistant Professor of Medicine Division of Gastroenterology and Hepatology UCH Crohn s and Colitis Center Mucosal Inflammation Program

More information

A disease and antibody biology approach to antibody drug discovery

A disease and antibody biology approach to antibody drug discovery A disease and antibody biology approach to antibody drug discovery Björn Frendéus, PhD VP, Preclinical research Presenter: Björn Frendéus Date: 2011-11-08 1 Antibodies have revolutionized Cancer Treatment!

More information

Alcoholic liver disease (ALD) and particularly

Alcoholic liver disease (ALD) and particularly FOCUS ON: ALCOHOL AND THE LIVER Gyongyi Szabo, M.D., Ph.D., and Pranoti Mandrekar, Ph.D. Thirty five years ago Charles Lieber and colleagues (1975) published a seminal article in liver research, showing

More information

DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE

DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE DIABETES AND INSULIN RESISTANCE KARI KOHRS RD LDN CDE UICMC NUTRITION & WELLNESS CENTER DIABETES PREVALANCE Third leading cause of death-- United States 18 million diagnosed Growing at the rate of 3 new

More information

Histological assessment of non-alcoholic fatty liver disease

Histological assessment of non-alcoholic fatty liver disease Histopathology 2006, 49, 450 465. DOI: 10.1111/j.1365-2559.2006.02416.x REVIEW Histological assessment of non-alcoholic fatty liver disease SGHübscher Department of Pathology, University of Birmingham,

More information

SHAHID AZIZ DO, FACOI.

SHAHID AZIZ DO, FACOI. SHAHID AZIZ DO, FACOI. ASSOCIATE CLINICAL PROFESSOR OF GI AND LIVER DISEASE. UT SOUTHWESTERN HEALTH SCIENCE CENTER, DALLAS ADJUNCT CLINICAL ASSISTANT PROFESSOR DEPT OF MEDICINE UNT HEALTH SCIENCE CENTER

More information

Corporate Presentation

Corporate Presentation Corporate Presentation September 17, 2015 NASDAQ: GALT www.galectintherapeutics.com 2015 Galectin Therapeutics Inc. Forward-Looking Statements This presentation contains, in addition to historical information,

More information

VPM 152. INFLAMMATION: Chemical Mediators

VPM 152. INFLAMMATION: Chemical Mediators General Pathology VPM 152 INFLAMMATION: Chemical Mediators CHEMICAL MEDIATORS OF INFLAMMATION Definition: any messenger that acts on blood vessels, inflammatory cells or other cells to contribute to an

More information

The Physiology of Hyperbaric Oxygen Therapy. Free Radicals and Reactive Oxygen Species. I. Introduction Definition, Source, function and Purpose

The Physiology of Hyperbaric Oxygen Therapy. Free Radicals and Reactive Oxygen Species. I. Introduction Definition, Source, function and Purpose The Physiology of Hyperbaric Oxygen Therapy Free Radicals and Reactive Oxygen Species I. Introduction Definition, Source, function and Purpose A. Definition of free radicals and reactive oxygen species

More information

Differential Diagnosis of NAFLD- A Short Summary:

Differential Diagnosis of NAFLD- A Short Summary: Differential Diagnosis of NAFLD- A Short Summary: Almost a fifth of our general pediatric population is now classified as overweight in the United States. When such children present with elevated liver

More information

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015 The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response

More information

NAFLD/NASH: Criteri diagnostici e prognostici

NAFLD/NASH: Criteri diagnostici e prognostici Monotematica AISF Personalizzazione della Cura in Epatologia NAFLD/NASH: Criteri diagnostici e prognostici Pisa 17-19 ottobre 2013 Elisabetta Bugianesi MD, PhD Division of Gastro-Hepatology, University

More information

Alcoholic Liver Disease in Women

Alcoholic Liver Disease in Women Clinical Medicine Alcoholic Liver Disease in Women JMAJ 45(3): 111 117, 2002 Masayoshi YAMAUCHI Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei

More information

Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic. syndrome and diabetes.

Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic. syndrome and diabetes. European Review for Medical and Pharmacological Sciences Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic syndrome and diabetes B. SEARS, C.

More information

MALIGNANT PLEURAL FLUIDS AID MESOTHELIOMA CELL GROWTH AND PROPAGATION

MALIGNANT PLEURAL FLUIDS AID MESOTHELIOMA CELL GROWTH AND PROPAGATION MALIGNANT PLEURAL FLUIDS AID MESOTHELIOMA CELL GROWTH AND PROPAGATION HUI MIN CHEAH PhD Candidate School of Medicine and Pharmacology University of Western Australia Lung Institute of Western Australia

More information

Healthcare Analytics. Aryya Gangopadhyay UMBC

Healthcare Analytics. Aryya Gangopadhyay UMBC Healthcare Analytics Aryya Gangopadhyay UMBC Two of many projects Integrated network approach to personalized medicine Multidimensional and multimodal Dynamic Analyze interactions HealthMask Need for sharing

More information

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Robyn Balden & Farida Sohrabji Texas A&M Health Science Center- College of Medicine ISC

More information

HCV and Diabetes. Francesco Negro. University Hospital of Geneva, Switzerland HepDART, Tuesday, December 10 th, 2013, Big Island, HI

HCV and Diabetes. Francesco Negro. University Hospital of Geneva, Switzerland HepDART, Tuesday, December 10 th, 2013, Big Island, HI HCV and Diabetes Francesco Negro University Hospital of Geneva, Switzerland HepDART, Tuesday, December 10 th, 2013, Big Island, HI Host genes Sedentary lifestyle HCV Drugs Environmental toxins (bisphenol

More information